Stepped-Care for Suicidal Youth and Children
SURE-CARE
Examining the Efficacy of a Stratified-Stepped-Care Model for Brief Interpersonal Couseling (IPC) in Youth With Imminent Suicidal Risk: A Prospective, Randomized Controlled Trial.
2 other identifiers
interventional
350
1 country
1
Brief Summary
The goal of this RCT study is to test the efficacy of a stratified stepped-care (SSC) model in reducing suicidal thoughts and behaviors (STB) in children and adolescents. The main questions it aims to answer are:
- 1.Does the SSC model effectively reduce STB and mental health symptoms?
- 2.Can the SSC model improve access to treatment and be cost-effective?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 7, 2024
CompletedFirst Submitted
Initial submission to the registry
September 28, 2025
CompletedFirst Posted
Study publicly available on registry
January 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
January 6, 2026
December 1, 2025
3.6 years
September 28, 2025
December 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from Baseline in Suicidal Thoughts and Behaviors (STB) as measured by the Columbia-Suicide Severity Rating Scale (C-SSRS).
This primary outcome measure assesses the change in the severity of suicidal thoughts and behaviors (STB) among participants over time, relative to their initial state at baseline. Data for this measure will be collected using the Columbia-Suicide Severity Rating Scale (C-SSRS). The C-SSRS is a standardized, clinician-administered tool that consists of a series of questions designed to identify, classify, and quantify the severity of a person's suicidal thoughts and behaviors. The scale addresses five types of suicidal ideation (e.g., thoughts of suicide without a plan or intent) and six types of suicidal behaviors (e.g., actual suicide attempts). The assessment is conducted at multiple time points. The change in C-SSRS scores between these time points will be used to compare the intervention group with the control group, determining whether the new treatment is more effective in reducing suicidal risk in children and adolescents.
Baseline, Week 4, Week 8, 12 Weeks Follow-up
Feasibility of SSC Model Integration
This measure evaluates the feasibility and fidelity of implementing the Stratified-Stepped-Care (SSC) model into the existing clinic workflow. Feasibility will be measured by calculating the percentage of adherence to the study protocol for both providers and participants (e.g., percentage of sessions completed, percentage of core protocol elements delivered). Fidelity will also be assessed via direct observation and completion of a standardized Protocol Adherence Checklist. Higher percentages indicate greater feasibility and fidelity to the SSC model and a better outcome.
From randomization up to one year after baseline.
Secondary Outcomes (13)
Depression: Measured by the Mood and Feelings Questionnaire (MFQ).
Baseline, Week 4, Week 8, 12 Weeks Follow-up
Total Cost of Mental Health Service Delivery per Participant
From randomization up to 6 months post-baseline.
Time (in Days) from Initial Intake to First Therapeutic Session
Initial Intake (Day 1) up up to first session of intervention
Change from Baseline in Anxiety Symptoms as measured by the Screen for Child Anxiety Related Emotional Disorders (SCARED).
Baseline, Week 4, Week 8, 12 Weeks Follow-up
Outcome Rating Scale (ORS) /Child Outcome Rating Scale (CORS)
Baseline, Week 4, Week 8, 12 Weeks Follow-up
- +8 more secondary outcomes
Study Arms (2)
Intervention Arm: Stratified Stepped Care (SSC)
EXPERIMENTALThe role of this arm is to test the efficacy of a new, tiered model for treating suicidal thoughts and behaviors (STB) in youth. Participants in this group will receive an intervention that is tailored to their specific needs and level of risk, as determined by an initial clinical assessment. Low-Intensity Treatment: Participants with mild-to-moderate STB will receive an adapted form of Interpersonal Counseling (IPC-A-SCI) delivered by a trained non-specialist. This intervention focuses on safety planning and improving interpersonal skills. High-Intensity Treatment: Participants with more severe STB, or those whose condition worsens, will receive Interpersonal Psychotherapy (IPT-A-SCI) from a professional therapist. This provides a clear "step-up" pathway to a more intensive level of care.
Control Arm: Care as Usual (CAU)
ACTIVE COMPARATORThe role of this arm is to serve as a comparison group to the SSC model. It represents the standard of care currently available in a public outpatient clinic in Israel. Standard Treatment: Participants in this arm will receive an initial psychiatric assessment. They will then be placed on a waitlist for a brief IPT intervention. Follow-up assessments will be conducted every three months. After completing the brief IPT, some participants may be referred to community services, and a small percentage may receive longer-term psychotherapy.
Interventions
The IPT-A-SCI is a crisis-focused psychotherapeutic intervention developed for adolescents with suicidal thoughts and behaviors. It is based on the principles of Interpersonal Psychotherapy (IPT).
The IPC-A-SCI is a manualized, low-intensity intervention adapted for adolescents experiencing suicidal thoughts and behaviors. It is based on Interpersonal Psychotherapy (IPT) principles but is designed to be delivered in a limited number of sessions by trained non-specialists. The protocol focuses on identifying and addressing interpersonal problems that may trigger or maintain suicidal behaviors. It includes core components such as safety planning, building interpersonal skills, and emotional processing, with a specific emphasis on involving parents in the treatment process. The intervention is a key component of the overall stratified stepped-care (SSC) model, which aims to provide targeted, effective, and accessible care in a public health setting.
Eligibility Criteria
You may qualify if:
- Participants must be between 6 and 18 years old, inclusive.
- Participants currently exhibit various forms of STB, including suicidal thoughts, gestures, behaviors, or attempted suicide.
You may not qualify if:
- Acute medical conditions.
- Current psychotic disorders.
- Non-fluency in Hebrew (language of intervention and assessment).
- Diagnosed intellectual disability.
- Diagnosed neurodevelopmental disorders (other than those that commonly co-occur with STB and are deemed manageable by the study team).
- Inability to provide informed consent (participant) or parental permission (parent/guardian).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shira Barzilaylead
- Schneider Children's Medical Center, Israelcollaborator
Study Sites (1)
Shneider children's Medical Center
Petah Tikva, 4920235, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Although the therapists are aware of the type of treatment they are providing, the participants themselves are not aware of which research arm they belong to (the SSC group or the CAU group) at the time of allocation. They know that they are participating in a study to compare treatment methods, but the identity of the specific treatment they receive is only revealed to them upon the start of the treatment. This makes them "masked" for a certain period to prevent bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator Dr Shira Barzilay
Study Record Dates
First Submitted
September 28, 2025
First Posted
January 6, 2026
Study Start
May 7, 2024
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
January 6, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- 6 months after the publication of the primary manuscript, for a period of 3 years following the initial release date.
- Access Criteria
- Access to the Individual Participant Data (IPD) will be granted only to qualified researchers outside of the immediate study team. Access requires that the requesting researcher submit a methodologically sound proposal for secondary analysis, and this proposal must be approved by the study's scientific review committee or the Institutional Review Board (IRB) to ensure the proposed use is ethical and aligned with participant consent. The following study documents and data will be made available: * De-identified Individual Participant Data (IPD) * Study Protocol * Statistical Analysis Plan (SAP) * Informed Consent Form (ICF) Access is contingent upon the requester signing a formal Data Access Agreement (DAA), which legally mandates adherence to privacy protocols and ensures protection of the sensitive nature of the data (suicide risk in minors).The de-identified dataset and supporting files will be delivered via a secured, password-protected electronic platform.
The investigators plan to share de-identified Individual Participant Data (IPD) that underlie the results reported in this article, after de-identification. The data will be shared with researchers who provide a methodologically sound proposal and whose proposed use of the data has been approved by the study's scientific review committee or the institutional review board (IRB). Data will be available upon request to the Principal Investigator \[Shira Barzilay, PhD\], and will be delivered via a secured, password-protected electronic platform. Requestors will be required to sign a data access agreement (DAA) to ensure the protection of participant privacy and the sensitive nature of the data (suicide risk in minors). The data shared will include the research protocol, statistical analysis plan (SAP), and the anonymized dataset